Wordt geladen...
Dendritic cell immunotherapy in uterine cancer
Uterine cancer is the most common pelvic gynecological malignancy. Uterine sarcomas and relapsed uterine carcinomas have limited treatment options. The search for new therapies is urgent. Dendritic cell (DC) immunotherapy holds much promise, though has been poorly explored in uterine cancer. This co...
Bewaard in:
Hoofdauteurs: | , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Landes Bioscience
2014
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4186030/ https://ncbi.nlm.nih.gov/pubmed/25424788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.28716 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|